Reevaluating Liposomal Bupivacaine: Insights and Implications for Canine Pain Management

11/02/2025 17 min
Reevaluating Liposomal Bupivacaine: Insights and Implications for Canine Pain Management

Listen "Reevaluating Liposomal Bupivacaine: Insights and Implications for Canine Pain Management"

Episode Synopsis

Send us a textJoin us as Drs. Vanna Dickerson and Danielle Hollenbeck discuss the impact of peri-incisional liposomal bupivacaine on postoperative pain scores, opioid use after soft tissue surgeries, and incidence of incision site complications in dogs. Despite its widespread use, liposomal bupivacaine may not be providing the pain relief many expect. With 83 dogs enrolled in their study, these findings challenge the status quo in veterinary medicine, emphasizing the importance of evidence-based care and cost-effectiveness. These revelations could reshape clinical practices, especially in cases where traditional analgesics fall short. Explore the nuances of their study and the broader implications for veterinarians striving to enhance patient outcomes.JAVMA article: https://doi.org/10.2460/javma.24.09.0589INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ? JAVMA ® : https://avma.org/JAVMAAuthors AJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® : Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

More episodes of the podcast Veterinary Vertex